The continuum of valvular heart disease: A lifetime management approach
The session underscored the importance of a lifetime management approach in structural heart disease, emphasizing how current treatment decisions can influence future interventions across aortic, mitral, and tricuspid therapies. It also reinforced the need for flexible, patient-centric strategies supported by robust clinical evidence and advanced technologies.
LEARN MORE:
Related Videos
Anatomy for structural interventions therapies (ASD, PFO, LAAO)
Transcatheter tricuspid valve repair: Cases, tips and tricks
M-TEER: Best treatment strategies for FMR AND DMR
Latest evidence in patient selection for T-TEER
Echo procedural approach for transcatheter tricuspid repair
M-TEER: State of the art echocardiography imaging modalities
EHRA 2026 | Tutorials | PFA/LAAO
VANTAGE Trial - 1-year clinical outomes
TRENDING TOPICS
TIME TO ACT – Webinar Recordings
M-TEER: Best treatment strategies for FMR AND DMR
M-TEER: State of the art echocardiography imaging modalities